My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing ...in less than a minute.
1. Is Earum Pharmaceuticals Ltd a good quality company?
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Earum Pharmaceuticals Ltd is a below average quality company.
2. Is Earum Pharmaceuticals Ltd undervalued or overvalued?
The key valuation ratios of Earum Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Earum Pharmaceuticals Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Earum Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||||||
| ROCE % ⓘ | 11.6% | 14.7% | 17.9% | 17.4% | 12.7% | 3% | 8.9% | - | |||||
| Value Creation Index ⓘ | -0.2 | 0.1 | 0.3 | 0.2 | -0.1 | -0.8 | -0.4 | - | |||||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 18.6 | 23.3 | 35.4 | 50.7 | 55.1 | 41.1 | 21 | 21 | |||||
| YoY Gr. Rt. % | - | 25.7% | 51.8% | 43.1% | 8.7% | -25.5% | -48.8% | - | |||||
| Adj EPS ⓘ | 1 | 1.3 | 2.9 | 5.4 | 0.3 | 0 | 0.4 | 0.1 | |||||
| YoY Gr. Rt. % | - | 40% | 119.6% | 85.3% | -94.5% | -96.7% | 3500% | - | |||||
| BVPS (₹) ⓘ | 12.7 | 14.2 | 14.2 | 19.3 | 2.3 | 2.4 | 2.7 | 2.8 | |||||
| Adj Net Profit ⓘ | 0.1 | 0.1 | 0.9 | 1.7 | 1.8 | 0.1 | 2.2 | 1 | |||||
| Cash Flow from Ops. ⓘ | -0.3 | 0.1 | -7.1 | -0.5 | -3.5 | -7.1 | 2.6 | - | |||||
| Debt/CF from Ops. ⓘ | -7.2 | 24.1 | -1 | -20 | -2.7 | -1.6 | 3.4 | - | |||||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | NA | -2.1% | -25.4% | -48.8% | ||||||||
| Adj EPS ⓘ | NA | -23% | -59.5% | 3500% | ||||||||
| BVPS ⓘ | 0 | -28.2 | -48 | 15.3 | ||||||||
| Share Price | - | - | -18.4% | -70.5% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||||
| Return on Equity % ⓘ | 7.4 | 9.9 | 28 | 30.8 | 17.9 | 0.6 | 14.3 | 3.6 | ||||
| Op. Profit Mgn % ⓘ | 2.8 | 1.7 | 4.4 | 6.5 | 2.3 | -18.9 | -21 | -22.4 | ||||
| Net Profit Mgn % ⓘ | 0.6 | 0.6 | 2.5 | 3.3 | 3.3 | 0.2 | 10.6 | 2.9 | ||||
| Debt to Equity ⓘ | 1.4 | 1.4 | 1.7 | 1.6 | 0.6 | 0.8 | 0.5 | 0 | ||||
| Working Cap Days ⓘ | 0 | 149 | 155 | 151 | 182 | 264 | 479 | 364 | ||||
| Cash Conv. Cycle ⓘ | 0 | 71 | 89 | 96 | 112 | 205 | 443 | 210 | ||||
Debt to equity has declined versus last 3 years average to 0.52
Sales growth is good in last 4 quarters at 14.04%
Return on Equity has declined versus last 3 years average to 3.60%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years -59.48%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 0.1 | - |
| TTM Sales (₹ Cr.) | 21 | - |
| BVPS (₹.) ⓘ | 2.8 | - |
| Reserves (₹ Cr.) ⓘ | 5 | - |
| P/BV ⓘ | 0.87 | - |
| PE ⓘ | 23.34 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 2.20 / 8.38 |
| All Time Low / High (₹) | 2.20 / 26.40 |
| Market Cap (₹ Cr.) | 14.9 |
| Equity (₹ Cr.) | 12.3 |
| Face Value (₹) | 2 |
| Industry PE ⓘ | 47.7 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earum Pharmaceuticals
Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from 'Earum Pharmaceuticals Private Limited' to 'Earum Pharmaceuticals Limited' vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company post conversion.
Business area of the company
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.
Milestones:
2012: Incorporation of the Company in the name of 'Earum Pharmaceuticals Private Limited'.
2014-15: Total turnover of the Company reached to Rs. 8 crores.
2015-16: Crossed Turnover of Rs. 18 crores.
2016-17: Crossed Turnover of Rs. 23 crores.
2017-18: Crossed Turnover of Rs. 35 crores.
2019: Conversion of the Company from Private Limited to Public Limited Company.
Download APP
